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Globally, medical problems in pregnancy are an increasing chall enge, 
and in South Africa (SA) they account for almost 50% of all maternal 
deaths. While HIV remains the major cause of maternal mortality, 
non-HIV-related medical problems are increasingly significant.
Obstetric physicians have a specific role in managing pregnant 
and postpartum women with medical problems, and in partnership 
with obstetricians can contribute to reducing maternal morbidity 
and mortality. There are physiological changes in almost all systems 
in pregnancy, and changes in the cardiovascular and respiratory 
systems and haematological changes are particularly important 
when assessing the cause and management of medical problems in 
pregnant women. Medical problems in pregnancy may be unique to 
pregnancy, exacerbated by it, or unrelated to it. They may be present 
prior to pregnancy, or present for the first time in pregnancy. Some 
are worsened by pregnancy. Pregnant women may improve or remain 
stable, or their disease may predictably or unpredictably deteriorate.
In this issue of CME, Rosie Burton, Letitia Acquah and their 
team cover most of the major medical problems that generalists 
will encounter in their pregnant patients, with practical advice on 
management and referral.
Should HIV be a notifiable disease?
In 1988, when fewer than 100 people with HIV had been identified 
in SA, the question of notification was discussed in the SAMJ. At the 
time, the Minister of Health, Nkosazana Dlamini Zuma, strongly 
advocated notification of HIV. Venter and colleagues[1] rejoin the 
debate and suggest that its time is past, because access to HIV testing 
is now widespread and effective therapy is freely available. They argue 
that in 2014, setting up the notification debate as one of public health 
v. human rights is misguided; public health benefits are not large or 
even likely, and do not outweigh the human rights burdens. 
Routine postoperative troponin 
surveillance after non-cardiac surgery
The only way to identify patients who have had a postoperative 
troponin leak secondary to myocardial ischaemia after non-cardiac 
surgery (MINS) is to conduct routine postoperative troponin 
surveillance – especially as 65% of patients suffering a myocardial 
infarction postoperatively will be asymptomatic and will also not be 
recognised through serial ECG monitoring. Torborg et al.[2] conclude 
that this is a potentially cost-effective intervention, provided effective 
therapy is immediately provided in response to the troponin leak. 
The simple and inexpensive introduction of statin and aspirin 
therapy following diagnosis of MINS has the potential to prevent 
progression to myocardial infarction; whether such therapy may also 
decrease mortality is currently unknown.
Hepatitis B
From April 1995, the hepatitis B virus (HBV) vaccine was included 
in the SA Expanded Programme of Immunisation at 6, 10 and 14 
weeks of age. However, no ‘catch-up’ immunisation of older age 
groups was implemented. Spearman and Sonderup[3] make the case 
for ensuring a birth dose (within 12 - 24 hours of delivery) of HBV 
vaccine to all babies to prevent perinatal transmission. This is even 
more important when the mother has HIV/HBV co-infection, which 
increases the risk of perinatal transmission. Challenges will be faced 
in rural areas where there is a higher prevalence of hepatitis B and 
home births occasionally occur, but studies have confirmed the 
thermostabilty of HBV vaccines outside the cold chain, assisting 
access to the birth dose in rural areas. A four-dose schedule will be 
slightly more costly than the current three-dose schedule.
The prevalence of HBV infection in patients with haematological 
malignancies is higher than that in the general population because of 
the immune suppression induced by cytotoxic chemotherapy. Immune 
suppression may also lead to reactivation of occult HBV infection and 
increased HBV replication. A large group of patients attending the 
paediatric haematology and oncology unit at Steve Biko Academic 
Hospital in Pretoria did not have sufficient protective antibodies against 
HBV at first presentation, despite being vaccinated.[4] The authors 
suggest that since such patients are at risk of hepatitis B infection, 
active surveillance and continued screening for HBV must be done 
at first presentation of all patients attending a paediatric haematology 
and oncology unit, and regularly during treatment and follow-up. A 
programme to immunise all seronegative patients against HBV should 
be implemented, and the response to immunisation documented. The 
use of combined passive-active immunisation should be encouraged, 
especially in children with haematological malignancies and HIV-
infected children. An effective screening and vaccination programme 
in the unit should protect all patients from contracting HBV.
Treatment of atrial fibrillation in SA
Atrial fibrillation (AF) is the most common cardiac arrhythmia, with 
a prevalence of 5 - 6% in the 65-year-old population, which increases 
up to 10% in the population aged >80 years. In SA, the prevalence of 
AF in the urban Black population has recently been documented to 
be 7% in a cardiovascular disease cohort (8% of heart failure patients, 
4% of hypertensive patients, and 13% of valve disease patients). 
However, very little has been published on AF management outside 
the developed world. 
This prompted the Assessment of the Therapeutic Management 
of Patients with Atrial Fibrillation in South Africa (SAFIR-RSA), 
involving 302 AF patients (60% male) from 29 centres.[5] The principal 
objective was to assess the baseline characteristics of patients with AF 
and the treatment modalities utilised, particularly the use of rate and 
rhythm control strategies. The study also looked at hospitalisation rates 
and thromboembolic prevention. The mean age (standard deviation)
was 67 (13) years (range 21 - 95).  The mean waist circumference 
was 101.6 (17.8) cm and mean the body mass index 28.8 (5.9) kg/m2, 
indicating a high prevalence of overweight patients in the cohort. 
The single most prevalent clinical characteristic was hypertension 
(65.9%). Other coronary risk factors (dyslipidaemia 48.3% and diabetes 
15.6%) were also frequent.  Concomitant structural heart disease was 
common, with 27.5% having valvular disease (of which 79.5% had mitral 
valve disease), 26.8% coronary artery disease, and 32.5% heart failure. 
Notably, the prevalence of underlying comorbidities such as 
coronary artery disease, valvular disease and heart failure was similar 
(~20 - 30% for each) to those reported in the developed world. For 
stroke prevention, 75.2% were on warfarin, 39.4% on aspirin and 5% 
on clopidogrel. The authors concluded that AF is a significant burden 
in cardiology practice in this country, with considerable resource 
utilisation and morbidity for patients. The survey also highlighted 
a lack of rigour in applying definitions of rate control and under-
utilisation of antithrombotic therapy.
Rheumatic fever and RHD in Gauteng 
The last epidemiological study of rheumatic heart disease in 
schoolchildren, undertaken 30 years ago in 1972, found a very high 
prevalence of 6.9/1 000 in children in Soweto, Johannesburg. A 
marked decline in children presenting with acute rheumatic fever 
(ARF) and chronic rheumatic heart disease (RHD) over the past two 
decades has been observed at Chris Hani Baragwanath Academic 
Hospital in Soweto.[6] The number of children documented to have 
ARF and RHD declined from 64 in the year 1993 to 3 in 2010. 
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This decrease may be attributed to an improvement in socioeconomic 
conditions and better access to medical care for the referral 
population over the last two decades, mirroring the improved trend 
in socioeconomic status of SA’s population over the past 15 years. 
There has been an increase in the average annual household income, 
improved access to amenities such as electricity, and a decrease 
in the average household size. This improvement in lifestyle, with 
less overcrowding, may be important in decreasing exposure to the 
rheumatogenic strains of the streptococcus organism.  
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